Patent ID: 8198413

Claim:
An isolated antibody that is capable of binding to the CD151 protein and comprises: i) a light chain comprising CDR-L1, CDR-L2, and CDR-L3, wherein: CDR-L1 is chosen from SEQ ID No. 43 and SEQ ID No. 85; CDR-L2 is chosen from SEQ ID No. 44 and SEQ ID No. 86; CDR-L3 is SEQ ID No. 45; and ii) a heavy chain comprising CDR-H1, CDR-H2 and CDR-H3, wherein CDR-H1 is chosen from SEQ ID No. 46 and SEQ ID No. 87; CDR-H2 is chosen from SEQ ID No. 47 and SEQ ID No. 88; CDR-H3 is chosen from SEQ ID No. 48 and SEQ ID No. 89; or a CD151-binding fragment of said antibody.